Ambrx Biopharma Inc. - stock earnings
AMAM Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -23.0 million USD | 53000 USD |
| 2023Q2 | -17.8 million USD | 1.1 million USD |
| 2023Q1 | -15.3 million USD | 24000 USD |
| 2022Q4 | -13.3 million USD | 2.2 million USD |
| 2022Q3 | -13.3 million USD | 2.2 million USD |
| 2022Q2 | -28.8 million USD | 1.3 million USD |
| 2022Q1 | -21.2 million USD | 1.2 million USD |
| 2021Q4 | -21.2 million USD | 1.2 million USD |
| 2021Q3 | -19.5 million USD | 1.2 million USD |
| 2021Q2 | -14.5 million USD | 2.6 million USD |
| 2021Q1 | -14.5 million USD | 2.6 million USD |
| 2020Q4 | -5.6 million USD | 3.6 million USD |
| 2020Q3 | -5.6 million USD | 3.6 million USD |
| 2020Q2 | -2.7 million USD | 3.2 million USD |
| 2020Q1 | -2.7 million USD | 3.2 million USD |
AMAM Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -67.1 million USD | 4.1 million USD |
| 2022 | -78.0 million USD | 7.4 million USD |
| 2021 | -68.3 million USD | 7.5 million USD |
| 2020 | -17.8 million USD | 13.7 million USD |
| 2019 | -22.3 million USD | 10.3 million USD |
AMAM
Price: $28
52 week price:
Earnings Per Share: 0.42 USD
P/E Ratio: 66.14
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 261163
Market Capitalization: 1.8 billion